Close
ACHEMA MIDDLE EAST 2026

Johnson & Johnson COVID-19 Vaccine Booster Shot Authorized for Emergency Use by U.S. FDA

Johnson & Johnson announced the U.S. FDA has issued EUA for a booster dose of the Johnson & Johnson COVID-19 vaccine for adults aged...

GTP Bioways invests €12M in two GMP biopharmaceutical production units

GTP Bioways, a CDMO (Contract Development and Manufacturing Organization) specializing in the production of biotherapies and nanotherapies, announces an investment of €12M ($14M) into...

Silence and Hansoh partner to develop siRNA-based treatments

Silence Therapeutics and Hansoh Pharmaceutical have entered a partnership to develop small-interfering ribonucleic acid (siRNAs) drugs for three undisclosed targets using the former’s mRNAi...

UCB to license its AI technology that improves identification of Osteoporosis to ImageBiopsy Lab

UCB announced a strategic out-licensing of Artificial Intelligence (AI) based fracture identification technology, BoneBot, to ImageBiopsy Lab to bring the new identification tool to...

Ubiquigent Extends and Expands Drug Discovery Collaboration With Bristol Myers Squibb

Ubiquigent Limited announces the extension and expansion of its long-term collaboration with Bristol Myers Squibb. Under the terms of the agreement, Ubiquigent will provide...

WAPG and Astellas Announce Future Innovator Prize to Help Emerging Biotechs Accelerate Early Drug Discovery and Research Efforts

Life Science Newswire – Astellas Venture Management LLC, a wholly-owned venture capital subsidiary of Astellas Pharma Inc, and We are Pioneer Group (WAPG), the...

Aptar Pharma and i2c Pharmaceutical Services Announce Partnership for Next Generation Propellant Dispersible Tablet pMDI Technology

Aptar Pharma, a global leader in drug delivery systems, services and active material science solutions, and i2c Pharmaceutical Services, a leading service provider for...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...